Comparison 4. Failure to eradicate (follow‐up: between two to three weeks).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Rifampin versus placebo	3	326	Risk Ratio (M‐H, Fixed, 95% CI)	0.25 [0.16, 0.37]